Histopathological characteristics of prostate cancer lymph node metastasis with false-negative PSMA-PET/CT findings

被引：0
|
作者：
Kroon, L. [1 ]
Kweldam, C. [1 ]
van Leenders, G. [1 ]
机构：
[1] Erasmus MC Canc Inst, Rotterdam, Netherlands
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-27-05
引用
收藏
页码：S532 / S533
页数：2
相关论文
共 50 条
  • [1] Falsch-positive – falsch-negative Befunde – Stellenwert der PSMA-PET/CT beim Staging von Patienten mit ProstatakarzinomFalse-positive/false-negative findings: the value of PSMA-PET/CT in the staging of patients with prostate cancer
    Sebastian Lenart
    Tobias Maurer
    Journal für Urologie und Urogynäkologie/Österreich, 2023, 30 (3): : 94 - 99
  • [2] Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET
    Huebner, Nicolai A.
    Wasinger, Gabriel
    Rajwa, Pawel
    Resch, Irene
    Korn, Stephan
    Rasul, Sazan
    Baltzer, Pascal
    Pruger, Larissa
    Rauschmeier, Andreas
    Seitz, Christian
    Comperat, Eva
    Shariat, Shahrokh F.
    Grubmuller, Bernhard
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (04) : 115e9 - 115e16
  • [3] The Prognostic Value of Histopathological Nodal Features and PSMA-PET findings in Patients with Pelvic Lymph Node Metastases of Prostate Cancer after Extended Pelvic Lymph Node Dissection
    Meijer, D.
    Ettema, R. H.
    van Leeuwen, P. J.
    van der Poel, H. G.
    Hendrikse, N. H.
    Oprea-Lager, D. E.
    Bekers, E. M.
    Vis, A. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S203 - S203
  • [4] PSMA-PET/CT Detection of Prostate Cancer Metastasis to Thyroid and Cricoid Cartilages
    Sesler, Aaron
    Raichandani, Surbhi
    Eichhorn, Joshua
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [5] Prospective evaluation of PSMA-PET imaging for preoperative lymph node staging in prostate cancer
    Eiber, Matthias
    Maurer, Tobias
    Beer, Ambros
    Souvatzoglou, Michael
    Weirich, Gregor
    Kuebler, Hubert
    Gschwend, Juergen
    Wester, Hans
    Schwaiger, Markus
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [6] Validation of gallium-68 PSMA-PET/CT for primary lymph node staging in prostate cancer patients
    van Kalmthout, L.
    van Melick, H.
    Lavalaye, J.
    Meijer, R.
    Kooistra, A.
    de Klerk, J.
    Braat, A.
    Kaldeway, P.
    de Keizer, B.
    Lam, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S295 - S295
  • [7] Outcomes & predictors of progression: SBRT for lymph node oligorecurrent prostate cancer on PSMA-PET
    Werensteijn-Honingh, A.
    Wevers, A.
    Peters, M.
    Kroon, P.
    Intven, M.
    Eppinga, W.
    Jurgenliemk-Schulz, I.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S573 - S575
  • [8] The role of salvage lymph node dissection and PSMA-PET in recurrent prostate cancer Comment
    Kalampokis, Nikolaos
    Grivas, Nikolaos
    GLAND SURGERY, 2020, 9 (04) : 1080 - 1081
  • [9] Role of PSMA-PET/CT in staging Prostate Cancer
    Graziani, T.
    Scarlattei, M.
    Baldari, G.
    Migliari, S.
    Sammartano, A.
    Maestroni, U.
    Ruffini, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S544 - S544
  • [10] 3D Volumetric lymph node assessment based on CT versus PSMA-PET/CT in recurrent prostate cancer
    Giesel, Frederik
    Fiedler, Hannah
    Sterzing, Florian
    Flechsig, Paul
    Moltz, Jan
    Afshar-Oromieh, Ali
    Kopka, Klaus
    Choyke, Pete
    Haberkorn, Uwe
    Kratochwil, Clemens
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
12345